doi: 10.3389/fendo.2025.1569468 Received 31 January 2025 Accepted 27 May 2025 Published 18 June 2025 Corrected 02 October 2025 Volume 16 - 2025 Edited by Chanan Meydan, Rabin Medical Center, Israel Reviewed by Michail Kokkorakis, Harvard Medical School, United States Danny Sugimoto, Cedar Crosse Research Center, United States Updates Copyright 2025 Steenackers, Toumassian, Deleus, Mertens, Lannoo, Pazmino, van Laar, Van der Schueren and Vangoitsenhoven
Further studies are required to better understand how GGT1, other GGT family members and uncharacterized proteins with GGT activity contribute to extracellular GSH catabolism
Before using WEGOVY, tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys
What you need to qualify for a case review We are only reviewing cases with these diagnoses: Gastroparesis, stomach paralysis, gastric stasis Ileal or ileus obstruction, intestinal blockage, bowel obstruction Show proof that youre getting medical treatment Your medical records must show that you have been treated or hospitalized for one of the diagnoses above
